Literature DB >> 16861067

Cell biology of T cell activation and differentiation.

María Angélica Santana1, Fernando Esquivel-Guadarrama.   

Abstract

T cells are major components of the adaptive immune system. They can differentiate into two different populations of effector cells-type one and type two-and may also become tolerant. T cells respond to immune challenges by interacting with antigen-presenting cells of the innate immune system. These latter cells can identify the nature of any immune challenge and initiate adaptive immune responses. Dendritic cells are the most important antigen-presenting cells in the body. The T cell recognizes both peptides associated with MHC molecules on the antigen-presenting cells and also other molecules in a complex structure known as an immunological synapse. The nature of the antigen, the cytokine environment, and other molecules on the dendritic cell surface instruct the T cells as to the response required. A better understanding of the biology of T cell responses offers the prospect of more effective therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16861067     DOI: 10.1016/S0074-7696(06)50006-3

Source DB:  PubMed          Journal:  Int Rev Cytol        ISSN: 0074-7696


  14 in total

1.  A novel VIP signaling pathway in T cells cAMP-->protein tyrosine phosphatase (SHP-2?)-->JAK2/STAT4-->Th1 differentiation.

Authors:  Li Liu; Jui-Hung Yen; Doina Ganea
Journal:  Peptides       Date:  2007-03-31       Impact factor: 3.750

Review 2.  Interrupting cyclic dinucleotide-cGAS-STING axis with small molecules.

Authors:  Herman O Sintim; Clinton G Mikek; Modi Wang; Moloud A Sooreshjani
Journal:  Medchemcomm       Date:  2019-08-15       Impact factor: 3.597

3.  Uric acid enhances T cell immune responses to hepatitis B surface antigen-pulsed-dendritic cells in mice.

Authors:  Xiao-Jun Ma; De-Ying Tian; Dong Xu; Dao-Feng Yang; Hui-Fen Zhu; Zhi-Hui Liang; Zheng-Gang Zhang
Journal:  World J Gastroenterol       Date:  2007-02-21       Impact factor: 5.742

4.  In-vitro activation of cytotoxic T lymphocytes by fusion of mouse hepatocellular carcinoma cells and lymphotactin gene-modified dendritic cells.

Authors:  Xi-Ling Sheng; Hao Zhang
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

5.  Effect of multiple genetic polymorphisms on antigen presentation and susceptibility to Mycobacterium tuberculosis infection.

Authors:  Stewart T Chang; Jennifer J Linderman; Denise E Kirschner
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

Review 6.  Multifaceted Role of Neuropilins in the Immune System: Potential Targets for Immunotherapy.

Authors:  Sohini Roy; Arup K Bag; Rakesh K Singh; James E Talmadge; Surinder K Batra; Kaustubh Datta
Journal:  Front Immunol       Date:  2017-10-10       Impact factor: 7.561

7.  IL-12 Signaling Contributes to the Reprogramming of Neonatal CD8+ T Cells.

Authors:  Darely Y Gutiérrez-Reyna; Alejandra Cedillo-Baños; Linda A Kempis-Calanis; Oscar Ramírez-Pliego; Lisa Bargier; Denis Puthier; Jose D Abad-Flores; Morgane Thomas-Chollier; Denis Thieffry; Alejandra Medina-Rivera; Salvatore Spicuglia; Maria A Santana
Journal:  Front Immunol       Date:  2020-06-05       Impact factor: 7.561

8.  CD43 signals induce Type One lineage commitment of human CD4+ T cells.

Authors:  Oscar Ramírez-Pliego; Diana L Escobar-Zárate; Gemma M Rivera-Martínez; Mayte G Cervantes-Badillo; Fernando R Esquivel-Guadarrama; Gabriela Rosas-Salgado; Yvonne Rosenstein; M Angélica Santana
Journal:  BMC Immunol       Date:  2007-11-23       Impact factor: 3.615

9.  Capturing cell-fate decisions from the molecular signatures of a receptor-dependent signaling response.

Authors:  Dhiraj Kumar; Ravichandran Srikanth; Helena Ahlfors; Riitta Lahesmaa; Kanury V S Rao
Journal:  Mol Syst Biol       Date:  2007-12-04       Impact factor: 11.429

Review 10.  Metabolic Reprogramming and Longevity of Tissue-Resident Memory T Cells.

Authors:  Youdong Pan; Thomas S Kupper
Journal:  Front Immunol       Date:  2018-06-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.